Key drivers of migraine disease progression

At EAN 2022, Gisela Terwindt, Professor of Neurology, Leiden University Medical Centre, discussed key drivers for migraine progression including genetically-determined comorbidities of depression and anxiety; allodynia, where the head and other parts of the body are painful to touch; and medication overuse headache, wherein a vicious cycle can develop when a patient strives to take enough medication to relieve their symptoms but chronic use of such medication causes headache.

 

BE-NOTPR-0278, approval date 02/2023

You are leaving Progress in Mind
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intended for health care professionals.
All the information included in the Website is related to diseases, investigations and existing or potential treatment options and, therefore, directed to health professionals . The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Congress
Register for access to Progress in Mind in your country